Submission Details
| 510(k) Number | K241564 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 31, 2024 |
| Decision Date | August 02, 2024 |
| Days to Decision | 63 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K241564 is an FDA 510(k) clearance for the Actifuse ABX; Actifuse MIS; Actifuse Shape; ALTAPORE; ALTAPORE SHAPE; ALTAPORE MIS, a Filler, Bone Void, Calcium Compound (Class II — Special Controls, product code MQV), submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on August 2, 2024, 63 days after receiving the submission on May 31, 2024. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3045.
| 510(k) Number | K241564 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 31, 2024 |
| Decision Date | August 02, 2024 |
| Days to Decision | 63 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MQV — Filler, Bone Void, Calcium Compound |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3045 |